EUCTR2016-002069-77-GR进行中（未招募）1 期
An Observational Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Have Previously Received RG-101
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Previously received at least one dose of RG-101 in a Regulus sponsored clinical study
- •2.Able and willing to adhere to the study visit schedule and comply with all other protocol requirements
- •3.Capable of and willing to provide written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 180
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •1.Currently participating in any follow-up period of another RG 101 clinical study.
- •Note: Participation in other investigational studies after the conclusion of the parent RG 101 study and/or concurrently with this observational study is allowed.
研究者
相似试验
进行中（未招募）
1 期
Follow-Up clinical trial in patients who have previously received test product RG-101 for assessment of long term safety and efficacyHepatitis C PatientsMedDRA version: 19.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: LLTClassification code 10019761Term: Hepatitis cytomegalovirusSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: LLTClassification code 10057394Term: Hepatitis C positiveSystem Organ Class: 100000004848MedDRA version: 19.0Level: LLTClassification code 10019760Term: Hepatitis CMVSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: LLTClassification code 10047457Term: Viral hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-002069-77-HURegulus Therapeutics Inc.200
进行中（未招募）
不适用
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis.Rheumatoid arthritisEUCTR2009-016119-38-PLAmgen Inc220
进行中（未招募）
不适用
Safety and Efficacy of AMG 827 in Subjects With RAMedDRA version: 13.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2009-016119-38-GBAmgen Inc220
进行中（未招募）
不适用
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis.MedDRA version: 12.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2009-016119-38-BGAmgen Inc220
进行中（未招募）
不适用
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With PsoriasisModerate to severe plaque psoriasisMedDRA version: 17.0Level: PTClassification code 10037153Term: PsoriasisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2009-016163-12-DKAmgen Inc160